http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108997428-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C65-21
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C51-43
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C65-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
filingDate 2018-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-108997428-B
titleOfInvention Co-crystal of tenofovir alafenamide and vanillic acid and preparation method thereof
abstract The invention discloses a tenofovir alafenamide and vanillic acid eutectic crystal and a preparation method thereof. The structural formula of the eutectic is as follows: in the eutectic, the molar ratio of tenofovir alafenamide to vanillic acid is 1: 1. Also discloses a preparation method of the eutectic crystal and application of the eutectic crystal. The tenofovir alafenamide-vanillic acid eutectic provided by the invention has higher melting point, improved thermal stability and improved hygroscopicity, reduces the sensitivity to environmental humidity and temperature in the preparation and storage processes, simplifies the production and post-treatment processes of medicines, reduces the material storage and quality control cost, has stronger economic value, and is more suitable for being used as a raw material medicine. In addition, the crystal has good crystallinity, is easy to prepare and is suitable for industrial large-scale production.
priorityDate 2018-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110234655-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016205141-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6569
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID971
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505042
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9574768
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419539429
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20284604
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454270468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516606
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448329161
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450151987
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID464205
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419577911
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410431024
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22018518
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22504236
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8468

Total number of triples: 41.